Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Men's thigh hair grows longer and has a longer growth cycle than women's, but arm hair growth is similar between genders.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Healthy women tend to lose more hair in July and April, and the least in February.

Finasteride use may cause sperm damage and infertility, stopping it can improve sperm health.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Antidepressants can cause long-term side effects like severe withdrawal symptoms and sexual dysfunction, which can last for months or years after stopping the medication.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

Most Sudanese married women in the study used contraceptives and knew about them, but many didn't know about emergency contraceptives or extra benefits beyond family planning.

Minoxidil and spironolactone slow hair loss in women.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Hair transplantation is the best treatment for hair loss, with new technologies improving results, and stem cell and gene therapies may treat severe baldness in the future.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.